Advertisement
Screener

PDS Biotechnology Corp (PDSB) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

1.7 / 5 stars · 20/59 Roast Me

PDS Biotechnology Corp Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

PDS Biotechnology Corp (PDSB) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 26.13 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13

  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 23.97M shares, a 79.81% increase year-over-year.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 13.33M shares, a 130.63% increase year-over-year.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 5.78M shares, a 0.37% decline year-over-year.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 5.80M shares, a 43.02% increase year-over-year.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 21.29M shares, a 267.11% increase from fiscal 2024.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 5.80M shares, a 5.54% increase from fiscal 2023.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 5.50M shares, a 17.49% increase from fiscal 2022.
  • PDS Biotechnology Corp antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 4.68M shares, a 39.16% increase from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3026.13M shares
10-Q · filed 2026-08-13
2026-03-3123.97M shares
10-Q · filed 2026-05-14
2025-12-3121.29M shares
10-K · filed 2026-03-30
2025-09-3015.95M shares
10-Q · filed 2025-11-13
2025-06-3016.15M shares
10-Q · filed 2026-08-13
2025-03-3113.33M shares
10-Q · filed 2026-05-14
2024-12-315.80M shares
10-K · filed 2026-03-30
2024-09-305.98M shares
10-Q · filed 2025-11-13
2024-06-306.03M shares
10-Q · filed 2025-08-13
2024-03-315.78M shares
10-Q · filed 2025-05-14
2023-12-315.50M shares
10-K · filed 2025-03-27
2023-09-305.89M shares
10-Q · filed 2024-11-14
2023-06-305.83M shares
10-Q · filed 2024-08-13
2023-03-315.80M shares
10-Q · filed 2024-05-15
2022-12-314.68M shares
10-K · filed 2024-03-28
2022-09-304.88M shares
10-Q · filed 2023-11-14
2022-06-304.41M shares
10-Q · filed 2023-08-14
2022-03-314.06M shares
10-Q · filed 2023-05-15
2021-12-313.36M shares
10-K · filed 2023-03-28
2021-09-303.15M shares
10-Q · filed 2022-11-14
2021-06-303.41M shares
10-Q · filed 2022-08-08
2021-03-312.10M shares
10-Q · filed 2022-05-11
2020-12-311.85M shares
10-K · filed 2022-03-31
2020-09-301.84M shares
10-Q · filed 2021-11-10
2020-06-301.84M shares
10-Q · filed 2021-08-12
2020-03-311.61M shares
10-Q · filed 2021-05-13
2019-12-311.68M shares
10-K · filed 2021-03-18		1.68M shares
10-K · filed 2020-03-27
2019-09-301.67M shares
10-Q · filed 2020-11-13
2019-06-301.68M shares
10-Q · filed 2020-08-13
2018-12-312.13M shares
10-K · filed 2020-03-27		7.63M shares
10-K · filed 2019-02-21
2018-09-30638.61K shares
10-Q · filed 2019-11-07		7.83M shares
10-Q · filed 2018-11-01
2018-06-30638.61K shares
10-Q · filed 2019-08-01		7.47M shares
10-Q · filed 2018-08-01
2018-03-31638.45K shares
10-Q · filed 2019-05-14		7.42M shares
10-Q · filed 2018-05-01
2017-12-316.84M shares
10-K · filed 2019-02-21
2017-09-306.76M shares
10-Q · filed 2018-11-01
2017-06-306.72M shares
10-Q · filed 2018-08-01
2017-03-316.60M shares
10-Q · filed 2018-05-01
2016-12-315.86M shares
10-K · filed 2018-03-01
2016-09-305.71M shares
10-Q · filed 2017-11-01
2016-06-305.70M shares
10-Q · filed 2017-08-01
2016-03-315.72M shares
10-Q · filed 2017-05-03
2015-12-314.90M shares
10-K · filed 2018-03-01
2015-09-3022.50M shares
10-Q · filed 2016-11-01		22.50M shares
10-Q · filed 2015-11-06
2015-06-3021.98M shares
10-Q · filed 2016-08-03
2015-03-3113.00M shares
10-Q · filed 2016-05-03
2014-12-3111.84M shares
10-K · filed 2017-03-02
2014-09-309.06M shares
10-Q · filed 2015-11-06
2013-12-318.52M shares
10-K · filed 2016-03-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
SCYNEXIS INC (SCYX)United States$0.045B
Grace Therapeutics, Inc. (GRCE)$0.046B-1.83
VERU INC. (VERU)United States$0.043B-3.93
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Advertisement